Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.5749
|
0.6098
|
0.5581
|
0.5268
|
0.61
|
0.5899
|
|
|
38 667.79
|
182.00
|
0.55
|
0.5798
|
0.551
|
0.5001
|
0.5833
|
0.561
|
|
|
30 832.09
|
216.00
|
0.54
|
0.55
|
0.5615
|
0.551
|
0.617
|
0.551
|
|
|
96 128.81
|
299.00
|
0.5651
|
0.5898
|
0.5867
|
0.541
|
0.6299
|
0.5644
|
|
|
36 450.25
|
241.00
|
0.5714
|
0.6089
|
0.6099
|
0.5855
|
0.613781
|
0.5855
|
|
|
32 227.94
|
174.00
|
0.5901
|
0.6298
|
0.6035
|
0.5694
|
0.61665
|
0.61
|
|
|
77 454.41
|
366.00
|
0.6151
|
0.638
|
0.6094
|
0.57
|
0.65
|
0.6398
|
|
|
113 266.31
|
419.00
|
0.61
|
0.6347
|
0.6497
|
0.60
|
0.669799
|
0.62
|
|
|
109 427.87
|
526.00
|
0.645
|
0.6666
|
0.65
|
0.60
|
0.6785
|
0.6698
|
|
|
200 362.46
|
985.00
|
0.583
|
0.63
|
0.52
|
0.5075
|
0.7399
|
0.6349
|
|
|
508 245.67
|
1 806.00
|
Kineta, Inc. is a clinical-stage bio-pharmaceutical company. The Company focuses on the discovery and development of adaptive immunity and T cell therapies for the treatments for neuro-degenerative diseases. Kineta operates in the United States.